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Abstract. 
 
The major target tissues for Epstein-Barr vi-
rus (EBV) infection are B lymphocytes and epithelial 
cells of the oropharyngeal zone. The product of the 
EBV BZLF1 early gene, EB1, a member of the basic 
leucine-zipper family of transcription factors, interacts 
with both viral and cellular promoters and transcription 
factors, modulating the reactivation of latent EBV in-
fection. Here, we characterize a novel cellular protein 
interacting with the basic domains of EB1 and c-Jun, 
and competing of their binding to the AP1 consensus 
site. The transcript is present in a wide variety of human 
adult, fetal, and tumor tissues, and the protein is de-
tected in the nuclei throughout the human epidermis 
and as either grainy or punctuate nuclear staining in the 
cultured keratinocytes. The overexpression of tagged 
cDNA constructs in keratinocytes revealed that the 
NH
 
2
 
 terminus is essential for the nuclear localization, 
while the central domain is responsible for the interac-
tion with EB1 and for the phenotype of transfected ke-
ratinocytes similar to terminal differentiation. The gene 
was identiﬁed in tail-to-tail orientation with the 
periplakin gene (
 
PPL
 
) in human chromosome 16p13.3 
and in a syntenic region in mouse chromosome 16. We 
designated this novel ubiquitously expressed nuclear 
protein as ubinuclein and the corresponding gene as 
 
UBN1
 
.
Key words: Epstein-Barr virus • epidermis • protein–
protein interaction • keratinocyte differentiation • 
chromosome 16
 
Introduction
 
Epstein-Barr virus (EBV)
 
1
 
 is a human herpes virus that
persists in latency for the lifetime of the infected host.
Transmission by oral contact results in infection of the oral
and/or nasopharyngeal epithelium, and subsequent infec-
tion of B lymphocytes in the adjacent lymphoid tissue en-
sues. EBV replication is highly dependent on the state of
cell differentiation. In the oral epithelium, EBV replica-
tion is observed primarily in the upper spinous layer that
consists of the terminally differentiated nondividing cells.
EBV is also associated with human malignancies, such as
Burkitt’s lymphoma, nasopharyngeal carcinoma, Hodgkin’s
disease, and B and T cell lymphomas in immunocompro-
mized individuals (for reference, see Rickinson and Kieff,
1996). EBV-infected B lymphocytes from the peripheral
blood or in vitro infected B lymphocytes can proliferate
continuously in culture. While much investigation has
sought to elucidate EBV’s role in the immortalization and
transformation of B lymphocytes, little is known about the
molecular mechanisms underlying EBV’s lytic infection of
epithelial cells. Biological data are accumulating on a rep-
ertoire of EBV genes and molecular mechanisms by which
the productive cycle is reactivated in latently infected epi-
thelial cells, as well as the mechanisms by which reactiva-
tion can be suppressed.
During epithelial differentiation, major changes take
place in the gene expression and morphology of the differ-
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9
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2
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entiating cells. The undifferentiated cells of the basal cell
layer are responsible for the cell-basement membrane at-
tachment through the adhesion complexes, called hemi-
desmosomes. When the cells lose their contact to the base-
ment membrane, they start to travel towards the upper
layers of the epithelium, changing their appearance as typ-
ical for the terminally differentiated cells. The cell–cell
adhesion mediated through desmosomes and adhesion
junctions plays an important role in the integrity of epithe-
lium. The terminally differentiated keratinocytes flatten
and develop the cornified envelope, the structure around
the cell wall, which has a significant impact on the barrier
function of epithelia. The pattern of genes expressed
changes along the differentiation stage of the cells. Spe-
cific transcription factors and transcriptional regulators
contribute to the differentiation of epithelial cells (Fuchs,
1995; Eckert et al., 1997).
Many of the known transcriptional regulators have been
identified through DNA–protein or protein–protein inter-
actions. The EBV transcription factor EB1 (also called
ZEBRA, Z, or Zta) is a member of the basic leucine-zip-
per (bZIP) family (Farrell et al., 1989; Chang et al., 1990;
Lieberman and Berk, 1990). The bZIP transcription fac-
tors, including Jun, Fos, ATF/CREB, and C/EBP family of
proteins, form homo- and heterodimers through a coiled-
coil domain, also called a leucine zipper, and bind DNA
through a region rich in basic amino acids, located adja-
cent to the dimerization domain. The protein complexes
known as AP1 and AP2 have an important function in the
regulation of gene expression in the epithelial cells (Fuchs,
1995; Eckert et al., 1997). EB1 is a sequence-specific
DNA-binding protein that activates transcription from
specific EBV promoters, as well as the promoters of some
cellular genes, thereby initiating the viral lytic cascade.
The first 167 NH
 
2
 
-terminal residues of EB1 are involved in
the transcriptional activation, while the remaining 78 resi-
dues form the DNA binding and dimerization domains.
The retinoic acid receptors, RAR
 
a
 
 and RXR
 
a
 
 (Sista et al.,
1995), as well as p53 and p65 (Gutsch et al., 1994; Zhang et
al., 1994), have been shown to interact with EB1, suggest-
ing that the viral protein EB1 may influence cellular reg-
ulatory pathways. The protein–protein interactions be-
tween the basic domain of EB1 and the key cell cycle
control proteins are indeed involved in cell cycle arrest
(Rodriguez et al., 1999). The molecular functions by which
transcriptional regulators modulate polymerase II-medi-
ated gene expression are initiated by the recruitment of
components of the transcriptional preinitiation complex.
The components are thought to be involved either individ-
ually or as holoenzyme complexes with coactivators and
corepressors, and as complexes affecting chromatin orga-
nization (for references see Workman and Kingston, 1998;
Berger, 1999; Berk, 1999; Hampsey and Reinberg, 1999).
Activation of transcription by EB1 has been shown to oc-
cur in vitro by direct contact of TFIID (Lieberman et al.,
1997). A direct interaction between the basic domain of
EB1 and TBP has also been documented in vitro (Mikae-
lian et al., 1993b).
Two independent approaches reported in this study led
to the biological characterization of a novel nuclear pro-
tein in human cells. Initially, partial cDNA was isolated
through expression cloning while screening for cellular
 
factors interacting with EBV EB1 protein. Independently,
during characterization of the periplakin (
 
PPL
 
) locus
(Aho et al., 1999), another previously unrecognized gene
was identified. Further studies revealed that this gene is
ubiquitously expressed and encodes a nuclear protein, ca-
pable for interacting with viral and cellular transcription
factors. Consequently, we have designated this novel gene
as ubinuclein (
 
UBN1
 
). Here, we detail cloning and chro-
mosomal localization of the 
 
UBN1
 
 gene, its tissue-wide ex-
pression, and structural and functional characteristics of
the encoded protein, ubinuclein.
 
Materials and Methods
 
cDNA Cloning
 
A 1-kb partial cDNA clone was isolated through screening of the HeLa
cell cDNA library in 
 
l
 
gt11. About 4 
 
3
 
 10
 
5
 
 phages were screened with bio-
tinylated EB1, essentially as described by MacGregor et al. (1990). EB1
was produced in 
 
Escherichia coli
 
 BL21 (DE3) cells transformed by plas-
mid pET-3c (Novagen) carrying the EB1 cDNA Z2.25. The EB1 protein,
which lacked the first 25 amino acid residues, was purified as insoluble
granules by standard procedures. The purified granules were denatured
for 10 min at 68
 
8
 
C in 50 mM Hepes, pH 7.9, 1% NP-40, 1% 
 
b
 
-mercaptoeth-
anol, 8 M urea and renatured by dialysis against buffer III (20 mM Hepes,
pH 7.9, 20 mM KCl, 1 mM MgCl
 
2
 
, 0.5 mM DTT, 0.5 mM PMSF, 0.5 mM
Na-Metabisulfate, and 20% glycerol). Purified EB1 was biotinylated in
vitro by biotin-N-hydrosuccimide ester (EB1:ester 1/10) for 3.5 h at room
temperature. Biotinylation was stopped by making the reaction 0.1 M in
NH
 
4
 
Cl, followed by dialysis for 12 h at 4
 
8
 
C against buffer III.
Further screening of the 
 
l
 
gt11 library with the 1-kb VT4 clone as a
DNA probe resulted in isolation of the cDNA clone, ZAP5 (Z-associated
protein). Further 5
 
9
 
-sequences were obtained through the 5
 
9
 
-RACE ap-
proach using a set of nested ZAP5 specific primers, a 
 
l
 
gt11-specific
primer, and the phage DNA from human placental 
 
l
 
gt11 library (Strat-
agene) as a template for the PCR.
 
Genomic Cloning
 
The cloning and sequencing of the human periplakin gene (
 
PPL
 
)
 
 
 
was de-
scribed previously (Aho et al., 1999). During characterization of 
 
PPL
 
, the
P1 clone GS#14060 was used as a template for direct DNA sequencing,
which revealed the 3
 
9
 
-end of 
 
UBN1
 
. Genomic clones containing the
 
UBN1
 
 5
 
9
 
-exons were obtained by screening a human placental lambda-
FIX II library (Stratagene) with a 284-bp PCR product from the 5
 
9
 
-end of
cDNA, produced with primers 5
 
9
 
-AGA TGA CAC TTA TGA CAA
GGA-3
 
9
 
 and 5
 
9
 
-CGT TGT CAG AAG TAG AGC CA-3
 
9
 
, and 
 
32
 
P-
labeled by random priming. The exon–intron boundaries were confirmed
by direct sequencing of the phage DNA using cDNA-specific primers.
DNA sequences were obtained using the PRISM Ready Reaction
DyeDeoxy Terminator Cycle sequencing Kit, and the Applied Biosystems
Models 373A and 377 DNA sequencing systems. The DNA homology
searches were performed with the BLAST algorithm (Altschul et al.,
1997) and the sequences were edited and analyzed using MacVector 6.0
(Oxford Molecular).
 
Northern Analysis
 
Human cancer cell line multiple tissue Northern blot was obtained from
Clontech. The 284-bp PCR product described above was 
 
32
 
P-labeled and
used as a probe, and the RNA blot was hybridized according to the manu-
facturer’s instructions.
 
PCR Analysis of Multiple Tissue cDNA Panels
 
Human multiple tissue cDNA panels (human MTC panels I and II, hu-
man fetal MTC panel, and human tumor MTC panel) were obtained from
Clontech and used as templates for PCR analysis. The ubinuclein exon
1A-specific primer 5
 
9
 
-GGG ACC GGC ATG AGG AC-3
 
9
 
, exon 1B-spe-
cific primer 5
 
9
 
-GGT CAA GGA TCT AGG ATA CA-3
 
9
 
, and exon 2-spe-
cific primer 5
 
9
 
-AGA AGC CAT GCA GTG ACA C-3
 
9
 
, in combination
with an exon 2-specific reverse primer 5
 
9
 
-AGC TCT GGG TAG AAG 
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AAC T-3
 
9
 
, produced PCR fragments of 304, 483, and 243 bp, respectively.
PCR conditions were: 2 min at 94
 
8
 
C, followed by 38 cycles of 94
 
8
 
C for 20 s,
58
 
8
 
C for 30 s, and 72
 
8
 
C for 1 min. PCR was conducted using Taq DNA
Polymerase and the Q-solution provided with the kit (Qiagen). G3PDH-
primers, provided by Clontech with each MTC panel, were used as a con-
trol, and the PCR was performed for 30 s at 94
 
8
 
C, followed by 26 cycles of
94
 
8
 
C for 20 s and 68
 
8
 
C for 2 min. The PCR-products were separated on
1.5% agarose-TBE gels.
 
In Vitro Interaction Assays
 
Glutathione S-transferase (GST)–ZAP5 fusion protein was expressed in
 
E
 
.
 
 coli
 
, and purified according to the instructions (Pharmacia Biotech).
The GST–ZAP5 bound to glutathione agarose was incubated with in
vitro
 
-
 
translated (Promega) 
 
35
 
S-labeled EB1, ZJ (Giot et al., 1991; Mikae-
lian et al., 1993a) and C/EBP (Landschulz et al., 1988), essentially as de-
scribed by Manet et al. (1993). Bound proteins were loaded onto a 10%
SDS-PAGE and visualized by autoradiography.
 
Electrophoretic Mobility Shift Assay (EMSA)
 
EMSAs were performed by incubating 4 
 
3
 
 10
 
4
 
 cpm of 5
 
9 
 
32
 
P-labeled dou-
ble-stranded oligonucleotide probe, 5
 
9
 
-TCG ACG CGA AGC ACT GAC
TCA TGA AGG TGC-3
 
9
 
 (AP1 consensus site underlined) with 2 
 
m
 
l of
 
 
 
in
vitro-translated proteins for 30 min at room temperature in 20 mM Hepes,
pH 7.9, 100 mM KCl, 1 mM MgCl
 
2
 
, 0.5 mM DTT, 10% glycerol, and 1 
 
m
 
g
of poly(dI-dC) in a final volume of 20 
 
m
 
l. After incubation, the mixture
was loaded onto a 4.5% (wt/vol) polyacrylamide gel (29 to 1 cross-linked),
0.2
 
3
 
 TBE, and run at room temperature at 10 V/cm for 3 h. Protein–DNA
complexes were visualized by autoradiography.
 
Expression Constructs
 
The CMV-based expression vectors for EB1 (pCMV-EB1) and EB1-
GCN4 (pCMV-EB1/GCN4) have been described elsewhere (Segouffin et al.,
1996). The Flag-tagged ubinuclein constructs were prepared using the ex-
pression vector pRc/CMV (Invitrogen). The EB1 constructs with point
mutations in the basic domain or the basic domain replaced by the c-Jun
basic domain (ZJ) have also been described elsewhere (Mikaelian et al.,
1993a).
 
Cell Cultures and Transfection Studies
 
Primary foreskin keratinocytes and HaCaT keratinocytes were cultured in
the KGM medium containing 0.15 mM Ca
 
2
 
1
 
 (Clonetics). The transfec-
tions were executed using the FuGENE 6 transfection reagent according
to the instructions provided by the manufacturer (Boehringer Mannheim
Corp.). Cells were harvested 9 or 21 h after transfection, washed three
times with PBS, fixed for 5 min in absolute methanol at 
 
2
 
20
 
8
 
C, and pro-
cessed for indirect immunofluorescence (IIF).
 
Immunological Analysis of Ubinuclein Protein
 
Rabbit polyclonal antibody was raised against the bacterially expressed
ZAP5–GST fusion protein. Rabbit serum was passaged several times
through a glutathione Sepharose 4B GST column to bind the anti-GST
antibodies. The flow-through was loaded on the Glutathione Sepharose
4B GST–ZAP5 column to bind the antibodies, which were eluted at low
pH. AZ125 mAb against EB1 has been described (Mikaelian et al., 1993a).
Mouse anti–Flag-tag antibody M2 was purchased from Stratagene, and
mouse monoclonal antiactin antibody from Boehringer Mannheim Corp.
For the Western blot, cells were harvested 24 h after transfection,
washed three times with PBS, and dissolved directly into SDS-gel loading
buffer. Proteins were separated by SDS-PAGE on 10% acrylamide, trans-
ferred onto nitrocellulose membrane, and detected by the affinity-purified
ZAP5 antibody. The secondary antibody, conjugated with HRP, was de-
tected with Renaissance Western blot chemiluminescence reagent (New
England Nuclear Life Science Products).
A section of human newborn foreskin, embedded and frozen in the
OCT compound, was cut into 7-
 
m
 
m cryosections, which were air-dried.
Slides with tissue sections or with cultured keratinocytes were rinsed with
PBS, fixed in methanol at 
 
2
 
20°C for 5 min, cells were permeabilized with
0.1% Triton X-100 in PBS for 5 min at room temperature, washed three
times with PBS, and blocked with 1% BSA in PBS for 1 h at room temper-
ature. The primary antibodies were applied on the samples overnight at
4
 
8
 
C. After four washes with PBS, samples were incubated for 1 h at room
 
temperature with the species-specific secondary antibody conjugated to
Texas red or Fluorescein (Jackson Laboratories), washed four times with
PBS, and mounted with Anti-Fade (Molecular Probes). Sections and
slides were studied under fluorescent microscope (Axioskop; Carl Zeiss,
Inc.), images were stored with ImagePro Plus 4.0 imaging software (Media
Cybernetics) and processed with Photoshop 5.0 (Adobe Systems Inc.) and
Canvas 5 (Deneba Software).
 
Results
 
Molecular Cloning of the Human Ubinuclein Gene
and cDNA
 
We recently reported characterization of periplakin cDNA
and the corresponding gene (
 
PPL
 
)
 
 
 
(Aho et al., 1998,
1999). DNA sequences downstream from the periplakin
polyadenylation signal (AATAAA) obtained from the
genomic P1 clone GS14060 (GenBank/EMBL/DDBJ AF-
041004 and AF108459) were subjected to the homology
search by the BLAST algorithm (Altschul et al., 1997),
which revealed an unexpected match with a large number
of cDNA clones in the GenBank/EMBL/DDBJ EST data-
base. Furthermore, sequencing of the opposite end of the
P1 clone (GenBank/EMBL/DDBJ AF108458; Fig. 1 A)
revealed a 146-bp sequence with complete match within
the VT4 cDNA (GenBank/EMBL/DDBJ U19346), which
has been isolated by screening a HeLa cell expression li-
brary for proteins that bind to a negative regulatory ele-
ment (NRE1) in the long terminal repeat (LTR) of human
immunodeficiency virus type 1 (HIV1; Tesmer et al., 1993;
M. Bina, Purdue University, personal communication).
In an independent approach, human HeLa cell 
 
l
 
gt11
cDNA expression library was screened with the in vitro-
translated and biotinylated EBV transcription factor EB1.
Among the positive clones, one contained a 1-kb EcoRI
insert, identical to the VT4 cDNA, with an open reading
frame allowing the translation of the putative interacting
fusion protein, but did not contain either translation initia-
tion or termination codons. The 1-kb EcoRI fragment was
used as a DNA probe in a second screening of the 
 
l
 
gt11 li-
brary and a longer cDNA clone, ZAP5, was isolated.
Rapid amplification of the cDNA library DNA with a pair
of vector specific and cDNA-specific primers resulted in
the extension of the 5
 
9
 
-end by 1.5 kb of cDNA sequences
(Fig. 2). The 2.3-kb 3
 
9
 
-untranslated region (UTR), se-
quenced from a genomic P1 clone, was verified by DNA
sequencing of the PCR-products generated using specific
primers and a human keratinocyte cDNA library as a tem-
plate. A single polyadenylation signal, AATAAA, was de-
tected 2.3 kb downstream from the translation termination
codon TGA. Human EST sequences cover almost 80% of
the ubinuclein cDNA, including the 5
 
9
 
-end and the entire
3
 
9
 
-UTR (BLAST search of the dbEST 12/22/99).
 
Genomic Organization of UBN1
 
Sequencing of the P1 clone, combined with the isolation
and sequencing of overlapping genomic 
 
l
 
-clones, revealed
that the human ubinuclein gene spans 
 
z
 
70 kb of genomic
DNA on the short arm of chromosome 16 (Fig. 1 A). The
full-length ubinuclein cDNA sequence identified 18 dis-
tinct exons in the genomic DNA. Two alternative 5
 
9
 
-exons,
preceded by putative promoter sequences, were identified 
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from the genomic clone. The VT4 cDNA clone was found
to match with ubinuclein exons 7–15 and the 146-bp
matching sequence in the genomic DNA was subsequently
identified as exon 12 of 
 
UBN1
 
.
The two genes, 
 
PPL
 
 and 
 
UBN1
 
, reside in a tail-to-tail
orientation, the distance between the polyadenylation sig-
nals of the two human transcripts being 194 bp (GenBank/
EMBL/DDBJ AF041004; Fig. 1 B). Although 
 
UBN1
 
 and
 
PPL
 
 genes together extend 
 
.
 
150 kb of genomic se-
quences, the 23-kb central region of the P1 clone GS14060
contains 19 exons, which occupy 40% of the genomic
DNA encoding 76% of the two cDNA sequences. Inter-
estingly, a VT4 protein pseudogene was recently identified
in clone 551E13 on human chromosome Xp11.2-11.3
(GenBank/EMBL/DDBJ AL022163).
DNA sequencing of a mouse genomic clone down-
stream from the 3
 
9
 
-end of the periplakin gene, 
 
Ppl
 
 (Gen-
Bank/EMBL/DDBJ AF116523), revealed high homology
to the corresponding region in the human genomic clone.
The BLAST search of the EST database with mouse ge-
nomic sequence identified a set of mouse cDNA clones,
highly homologous to the human ubinuclein 3
 
9
 
-sequences,
confirming a tail-to-tail arrangement for 
 
Ppl
 
 and 
 
Ubn1
 
,
similar to the human genes. Although human and mouse
intergenic regions did not show sequence homology, the
distance between the two polyadenylation signals in mouse
was similar to that in human, 197 bp (Fig. 1 C).
 
Predicted Ubinuclein Amino Acid Sequence
 
The human ubinuclein open reading frame starts in exon 2
from an ATG codon which is preceded by an in-frame
translation stop codon, TAA, only six triplets upstream
(Fig. 2). The flanking sequence GtaGCCATGt surround-
ing the start codon is in agreement with the Kozak consen-
sus sequence GCC(A/G)CCATGG (Kozak, 1991, 1996).
The open reading frame within the full-length UBN1
cDNA encodes a polypeptide, 1,134 amino acids long, with
a calculated molecular mass of 121,529 D (Fig. 2).
 
 
 
The en-
 
tire protein is basic, pI 9.34, and rich in serine and lysine,
12.79% and 10.58%, respectively. The secondary structure
prediction suggests that the NH
 
2
 
-terminal half of the pro-
tein, which is mainly composed of charged amino acids,
forms several 
 
a
 
 helices, while the COOH-terminal half,
with polar/nonpolar amino acids dominating, is flexible
with high abundance of 
 
b
 
-turns. Five acidic regions were
identified within the NH
 
2
 
-terminal half of ubinuclein:
amino acids 31–56 with pI 5.31; amino acids 122–180 with
pI 3.52; amino acids 281–390 with pI 3.89; amino acids
450–503 with pI 5.01; and amino acids 621–720 with pI 4.71
(Figs. 2 and 6). The alternating acidic and basic domains
have a potential to form secondary structures, which are
known to interact with DNA. Indeed, the partial VT4
cDNA clone (GenBank/EMBL/DDBJ U19346), encoding
ubinuclein amino acids 346–693, was cloned through
DNA–protein interaction (see above; Tesmer et al., 1993).
Several clusters of basic amino acids, altogether 11,
which fulfill the requirements of either SV40-type (Kal-
deron et al., 1984) or nucleolin-type (Dingwall et al., 1988)
nuclear localization sequences, were identified. Especially,
the amino acids 180–262 segment contains five repeats
(Figs. 2 and 6). Computer prediction revealed abundance
of possible phosphorylation sites, including consensus se-
quences for protein kinase C, casein kinase II, cAMP
phosphokinase, and tyrosine phosphorylation. A domain
rich in serines (DRS) was identified within the COOH-ter-
minal region, amino acids 866–932, and a ATP/GTP bind-
ing site homologous to Walker A motif (Walker et al.,
1982) was identified at the COOH terminus, amino acids
1119–1127.
 
Interspecies Homology of the Ubinuclein Transcript
 
The homology between the human ubinuclein 5
 
9
 
-end with
557 bp of mouse EST sequences was 91%. In addition to
human and mouse ESTs, a cDNA clone from 
 
Sus scrofa
 
(emb/F23010/SSC18E02) showed 86% identity with the
5
 
9-end of human sequence. Alignment of the human 39-UTR
Figure 1. Genomic organiza-
tion of the periplakin/ubi-
nuclein locus on human
chromosome 16p13.3. A, Se-
quencing of the human ge-
nomic P1 clone, GS14060,
containing  PPL  disclosed the
presence of a novel gene,
UBN1. The orientation of
each gene is shown on top,
and the accession numbers
for the DNA sequences avail-
able from the GenBank/
EMBL/DDBJ are denoted in
the middle. The exons drawn
and placed in scale are shown
as black squares. B, Human
UBN1 and PPL genes were
found to reside in tail-to-tail
orientation. The distance between the corresponding polyadenylation signals (AATAAA and TTTATT, underlined) is 194 bp. The
ends of the cDNAs are indicated by brackets. C, The DNA sequencing of a mouse genomic l-clone revealed that the arrangement of
the mouse Ubn1/Ppl locus on the syntenic region of mouse chromosome 16 was similar to that of the human locus, and the distance
between the polyadenylation signals is 197 bp.Aho et al. Ubinuclein, a Novel Nuclear Protein 1169
Figure 2. Nucleotide sequence of the cDNA encoding ubinuclein
and the predicted amino acid sequence. Numbering of the cDNA
sequence begins from the first nucleotide of the putative transla-
tion initiation codon, ATG, which is preceded by an in-frame
stop codon, TAA, only six triplets upstream (underlined). Two
alternative 59-ends probably due to the multiple promoter usage,
denoted Exon 1A and Exon 1B, were discovered. Five nucleolin-
type acidic regions are highlighted by shading. Repeats of basic
amino acids with homology to nuclear localization signals are un-
derlined by dashed lines and numbered (1–11). The serine-rich
region is denoted with dotted underlining and the ATP/GTP con-
sensus binding sequence (amino acids 1119–1127) is underlined.
The open reading frame encoding a polypeptide of 1134 amino
acid residues terminates in a stop codon (indicated by an aster-
isk), which is followed by a consensus polyadenylation signal
(AATAAA, underlined) at the end of the 2280-bp 39-UTR.
These sequence data are available from GenBank/EMBL/DDBJ
under accession numbers AF108460 and AF108461.The Journal of Cell Biology, Volume 148, 2000 1170
sequences with the two contigs of mouse ESTs (696 and
907 bp) indicated 75% identity overall. An EST clone of
Rattus norwegicus (GenBank/EMBL/DDBJ AI112799;
Bonaldo et al., 1996) showed 96% identity to the 39-UTR
of the mouse ubinuclein. Collectively, the nucleotide se-
quence around the ATG codon and the 39-UTR se-
quences, especially those immediately surrounding the
AATAAA consensus signal, showed considerable homol-
ogy between human, mouse, rat, and pig, significantly
higher than would be expected from the 39-UTR extend-
ing .2 kb beyond the translation termination codon.
Ubinuclein Transcript is Constitutively Expressed in 
Fetal and Adult Tissues
Human multiple tissue cDNA panels were used as PCR
templates to study the ubinuclein expression in both adult
and fetal tissues. With the exon 2-specific primers, the ubi-
nuclein transcript was detected in all of the normal tissues,
as well as in a set of human tumor tissues (Figs. 3 and 4 A).
Ubinuclein cDNA cloning revealed two alternative 59-
ends, which were identified in the genomic clone as two al-
ternative exons, 1A and 1B, encoding two alternative 59-
UTRs (Fig. 2). The primers specific for exon 1A–exon 2
produced a PCR product from all the templates used,
while exon 1B–exon 2-specific primers produced a PCR
product from tumor cells, fetal tissues, and a limited num-
ber of adult tissues (Figs. 3 and 4 A).
The hybridization of human cancer cell line multiple tis-
sue Northern blot revealed that the transcript was present
in various cancer cell lines (Fig. 4 B). The 7-kb transcript
detected on the Northern blot is in agreement with the
6.3–7.0 kb of cloned cDNA sequences. On the Northern
blot, only a single band was detected, suggesting that one
of the alternatively used promoters was expressed on a rel-
atively low level. The BLAST search identified human
ESTs originating from a wide variety of tissues and cells,
including heart, retina, gall bladder, liver, testis, and ovary;
fetal heart, liver, and spleen; an ovarian tumor, an en-
Figure 3. Expression of ubinuclein transcripts in human adult and fetal tissues. The multiple tissue cDNA panels I and II (first two pan-
els), and human fetal panel (last panel) were used as PCR templates. PCR primers specific for exon 1A–exon 2, exon 1B–exon 2, and
exon 2 of ubinuclein, and for G3PDH as an internal standard, were used. cDNAs were derived from polyA1 RNA isolated from tissues
indicated on the top and the quantity was normalized against the transcripts of several housekeeping genes. In most tissues, transcripts
with exon 1A–exon 2-specific primers were detected at the equal level, whereas a transcript containing exon 1B was less abundant.
Figure 4. Expression of ubinuclein transcript in human tumor tis-
sues. A, Tumor tissue cDNA panel was used as a PCR template
as described in Fig. 3. Lane 1, Molecular weight marker, 100-bp
ladder; lane 2, negative control; lane 3, colon adenocarcinoma
(GI-112); lane 4, colon adenocarcinoma (CX-1); lane 5, pancre-
atic adenocarcinoma (GI-103); lane 6, prostatic adenocarcinoma
(PC-3); lane 7, lung carcinoma (GI-117); lane 8, lung carcinoma
(LX-1); lane 9, breast carcinoma (GI-101); lane 10, ovarian carci-
noma (GI-102). B, Northern blot analysis of human mRNA. Hy-
bridization of the human cancer cell line multiple tissue Northern
blot with the ubinuclein-specific probe revealed a transcript of 7 kb.
G3PDH-specific probe was used as a control. Lane 1, Promyelo-
cytic leukemia HL-60; lane 2, HeLa cells S3; lane 3, chronic myelog-
enous leukemia k-562; lane 4, lymphoblastic leukemia MOLT-4;
lane 5, colorectal adenocarcinoma SW40; lane 6, lung carcinoma
A549; lane 7, melanoma G361.Aho et al. Ubinuclein, a Novel Nuclear Protein 1171
dometrial tumor, and T cell lymphoma; as well as Jurkat T
cells and activated T cells. Furthermore, mouse EST
clones derived from various adult tissues, as well as from
unfertilized egg, 2-cell stage mouse embryo and 8.5-, 13.5-,
and 19.5-d mouse embryos were identified. One of the pig
39-UTR clones in the EST database has been identified by
differential hybridization of a granulosa cell cDNA library
(GenBank/EMBL/DDBJ no. X91689; Tosser-Klopp et al.,
1997).
Demonstration of the Nuclear Localization of 
Ubinuclein Protein
Because PCR analysis revealed that ubinuclein is a rela-
tively common transcript in human keratinocyte cDNA li-
brary (data not shown), we applied IIF analysis to study
the expression and localization of ubinuclein protein in
human skin and keratinocytes in culture. Frozen sections
of human newborn foreskin revealed intense nuclear sig-
nal with ZAP5 antibody throughout the epidermis (Fig. 5
A). Human foreskin keratinocytes in culture showed stain-
ing both in fine granular nuclear pattern, as well as in dis-
tinct nuclear dots (Fig. 5 B).
Flag epitope-tagged full-length ubinuclein cDNA, Ubi-F
(amino acids 1–1134); an NH2-terminally deleted cDNA,
Ubi-Z (amino acids 204–1134, ZAP5); and the NH2-termi-
nal construct, Ubi-N (amino acids 1–347; Fig. 6); under the
control of the CMV promoter, were transiently transfected
into keratinocytes. Cells transfected with Ubi-F and Ubi-N
showed strong nuclear signal with the ZAP5 antibody, but
Ubi-Z/ZAP5 was distributed both in the nucleus and in
the cytoplasm (Fig. 7 A). Double-labeling with Flag-tag an-
tibody M2 showed colocalization with ZAP5 antibody
staining in each case. However, transient transfections with
Ubi-N and Ubi-Z resulted in the overexpression of the
transfected construct, which, in microscopic images, masked
the endogenous ubinuclein signal of the adjacent cells (Fig.
7 A). The strongest signal of overexpressed Ubi-F and Ubi-N
within the nuclei colocalized with the signal obtained with
an antibody against nucleoli (results not shown).
Overexpression of Ubinuclein cDNA in Cultured 
Keratinocytes Results in Morphological Changes 
Resembling Terminal Differentiation
Overexpression of the full-length Ubi-F, but not Ubi-Z or
Ubi-N, resulted, after the initial nuclear localization, in the
spreading of the transfected cells and redistribution of the
Flag-tagged Ubi-F into the cytoplasm. A circular pattern
of dots radiating from the nucleus was often distinguished
from the uniform cytoplasmic staining (Fig. 7 A, Ubi-F
panel on right). Remains of cells, seen on the top of the
basal cell layer and strongly staining with ZAP5 and M2
antibodies, suggested disintegration and shedding of the
transfected cells, resembling the terminal differentiation
of primary keratinocytes in culture (Fig. 7 B).
On the Western blot, the ZAP5 antibody detected a
150-kD band from the keratinocyte extract (Fig. 8). From
the cell cultures expressing full-length construct Ubi-F, a
single band of 150 kD was detected, while the polypeptide
encoded by Ubi-Z/ZAP5 construct appeared as a slightly
faster migrating band, and Ubi-N polypeptide was seen as
a 50-kD band. In latter cases, the endogenous 150-kD
band was also detected (Fig. 8).
EB1 Expression Interferes with Endogenous Expression 
of Ubinuclein
As ubinuclein was initially identified through interaction
Figure 5. Nuclear localization of the ubinuclein protein. IIF of a
newborn foreskin (A) and primary foreskin keratinocytes in cul-
ture (B). Top of B shows Ubi-Z/ZAP5 antibody staining visual-
ized with Texas red, whereas nuclei are shown by DAPI in the
bottom panel.
Figure 6. Organization of the deduced ubinuclein polypeptide.
Acidic regions are shown as ovals 1–5, serine-rich domain is de-
noted as a striped box, and the basic nuclear localization signal-
like regions are indicated by arrows. The expression constructs, a
full-length ubinuclein (Ubi-F), NH2-terminal construct (Ubi-N),
and NH2-terminally deleted cDNA (Ubi-Z/ZAP5), as well as
the original VT4 clone (GenBank/EMBL/DDBJ U19346), are
aligned with the amino acid sequence and denoted with horizon-
tal bars.The Journal of Cell Biology, Volume 148, 2000 1172
Figure 7. Expression of transiently transfected ubinuclein constructs Ubi-F, Ubi-N, and Ubi-Z/ZAP5, as well as EB1 in primary fore-
skin keratinocytes. The cultures were stained either with ZAP5 antibody detecting both endogenous and transfected ubinuclein, with
M2 antibody recognizing the Flag-tag, or with DAPI for DNA to visualize the nuclei. A, NH2-terminal 345 amino acids contain suffi-
cient information for the nuclear localization of ubinuclein. Cells were prepared for IIF 9 h after transfection of the expression con-
structs denoted on the top of each panel. Flag-tag signal (M2 ab) colocalized with the signal obtained with ZAP5 antibody. The endog-Aho et al. Ubinuclein, a Novel Nuclear Protein 1173
with EB1 protein, we overexpressed EB1 in primary kera-
tinocytes by transiently transfecting cells with an expres-
sion construct under the control of CMV promoter. IIF re-
vealed that, in the cells where EB1 was overexpressed, the
endogenous ubinuclein signal was either undetectable or
weaker than in untransfected neighboring cells (Fig. 7 C).
Cotransfection and subsequent overexpression of the full-
length ubinuclein, Ubi-F, together with EB1, resulted in a
similar appearance of cells as detected with the Ubi-F con-
struct (Fig. 7 D). The colocalization of ubinuclein and EB1
was first limited to the nucleus. However, both proteins
were also detected in the cytoplasm of the cells that ap-
peared flat and were spread out on the top of the basal cell
layer (Fig. 7 D), whereas the cells expressing only EB1
showed normal cellular morphology and exclusively nu-
clear staining with EB1 antibody (Fig. 7 C). The distinct
cytoplasmic colocalization in a punctate pattern suggests
that ubinuclein and EB1 are capable of interacting in vivo.
Ubinuclein Interacts In Vitro with the Basic Domain of 
both Cellular and Viral bZIP Transcription Factors
Because a partial ubinuclein cDNA clone was originally
isolated through the interaction with EB1, we wanted to
identify the domain in EB1 responsible for the interaction.
A polypeptide, encoded by Ubi-Z/ZAP5 cDNA (Fig. 6),
was expressed as a GST fusion protein in E. coli and im-
mobilized to glutathione agarose particles. A series of in
vitro-translated EB1 polypeptides with deletions within
each domain and point mutations within the basic domain
(Fig. 9 A) was tested for the affinity to the Ubi-Z/ZAP5
polypeptide. We observed that the interaction between
Ubi-Z/ZAP5 and EB1 was impaired when the EB1 basic
domain (Fig. 9 B, lane 4) or the EB1 dimerization domain
(Fig. 9 B, lane 5) was deleted. To pinpoint the amino acids
within the EB1 basic domain critical for the binding to
Ubi-Z/ZAP5, we assessed the ability of three EB1 con-
structs carrying point mutations, Z306, Z310, and Z311, to
enous signal was detectable with ZAP5 antibody in a panel transfected with Ubi-F, but the strong expression of the Ubi-N and Ubi-Z
masked the endogenous signal in the adjacent cells. B, Cells were prepared for IIF 21 h after transfection with the full-length ubinuclein,
Ubi-F. A and B, Ubi-F overexpression makes the transfected keratinocytes migrate from the basal cell layer, spread on the top of the
basal cell layer, and finally disintegrate and shed off. C, EB1 overexpression downregulates the immunodetectable endogenous ubinu-
clein. Primary keratinocytes transiently transfected with the EB1 expression construct under the CMV promoter showed strictly nuclear
localization in IIF for the EB1 protein. Only in a mitotic cell (see EB1 ab, green cell on the left) EB1 is temporarily released from the
nucleus. D, The coexpression of EB1 and Ubi-F results in the cytoplasmic colocalization of EB1 and Ubi-F proteins. ZAP5 antibody
was used to detect the ubinuclein protein (Texas red, A–D); M2 antibody was used to detect the Flag-epitope–tagged recombinant pro-
teins (FITC, green, A and B); EB1 protein was detected with antibody AZ125 and visualized with anti-mouse–FITC (green, C and D).
DNA in nuclei is demonstrated with DAPI staining and triple filter (blue staining in A–D). Bars, 10 mm.
Figure 8. Western blot anal-
ysis of the endogenous ubi-
nuclein and the polypeptides
expressed from the tran-
siently transfected expression
constructs. Total extracts of
HaCaT keratinocytes (con-
trol) and of those transfected
with the Ubi-F, Ubi-N, and
Ubi-Z/ZAP5 expression con-
structs were separated on a
10% SDS-PAGE and de-
tected with ZAP5 antibody
(top). The same blot was
stained with antiactin antibody (bottom). The arrows point to the
bands corresponding to the full-length ubinuclein (top), and
polypeptides encoded by Ubi-Z/ZAP5 (middle) and Ubi-N (bot-
tom) expression constructs.
Figure 9. Ubinuclein binds to the basic domain of EB1. A, The
EB1 protein is composed of the activation domain (amino acids
1–175), DNA-binding domain (DB; amino acids 178–195), and
the dimerization domain (Di; amino acids 196–233). A set of de-
letion constructs and amino acid substitutions were prepared, as
indicated in the bottom of A. B, The interaction between the in
vitro-translated EB1 constructs (a) and Ubi-Z/ZAP5 (b) was im-
paired by the deletion of EB1 DNA-binding domain (lane 4),
mutations in the EB1 DNA-binding domain (lanes 7 and 8), or
the deletion of the dimerization domain (lane 5). Ubi-Z/ZAP5–
GST fusion protein bound to the GT-agarose was used as the af-
finity matrix. Asterisk marks the low molecular weight protein,
Z42-199 (a, lane 4).The Journal of Cell Biology, Volume 148, 2000 1174
interact with GST-Ubi-Z/ZAP5. As shown in Fig. 9 B,
Z306 did not bind to Ubi-Z/ZAP5 at all (Fig. 9 B, lane 7)
and Z310 bound only weakly (Fig. 9 B, lane 8), whereas
Z311 bound as avidly as the wild-type EB1 (Fig. 9 B, lane
9). Thus, within the bipartite basic domain of EB1, the ba-
sic amino acid residues are essential for binding, but an
alanine to lysine substitution between the two basic re-
gions did not affect the binding.
As shown above, EB1 interacts directly in vitro with
Ubi-Z/ZAP5, and although the dimerization domain is re-
quired, this binding seems to involve specific residues in
the region rich in basic amino acids. Therefore, we evalu-
ated if this interaction was restricted to EB1 or if ubinu-
clein might also interact with other members of the bZIP
family of proteins. As shown in the in vitro pull-down as-
say (Fig. 10 A), GST-Ubi-Z/ZAP5 showed significant af-
finity to the in vitro-translated EB1, to its derivative ZJ
(the basic domain of EB1 replaced by the c-jun basic do-
main), and to C/EBP, whereas GST alone did not show in-
teraction.
Since ubinuclein appeared to interact with the bZIP
protein basic domain, which makes direct contact with
DNA, we postulated that Ubi-Z/ZAP5 might impair the
binding of EB1 to DNA. Indeed, in an EMSA, increasing
amounts of the in vitro-translated Ubi-Z/ZAP5 impaired
the binding of in vitro-translated EB1 to an oligonucle-
otide containing an AP1 consensus binding site (Fig. 10
B). Since the dimerization domain of EB1 is essential for
the formation of Ubi-Z/ZAP5-EB1 complex in vitro, we
examined whether specific amino acids within the dimer-
ization domain were required for the formation of this
complex. The dimerization domain of EB1 was replaced
by the homodimerization domain of the yeast transcrip-
tional activator, GCN4. The in vitro-translated hybrid pro-
tein EB1gcn4 bound to the AP-1 consensus oligonucleotide,
and the complex formation was competed by increasing
amounts of in vitro-translated Ubi-Z/ZAP5 (Fig. 10 B).
Collectively, our results strongly suggest that the dimeriza-
tion of EB1 is necessary for the binding, whereas critical
amino acid residues within the basic domain of EB1 are
specifically involved in binding to ubinuclein.
Discussion
In this study, we report the molecular cloning and biologi-
cal characterization of a novel gene actively expressed in a
variety of tissues and cell lines. The protein is able to bind
directly to both viral and cellular transcription factors, and
both the endogenous protein and Flag-tagged recombi-
nant protein encoded by an expression construct show nu-
clear localization. Hence, the protein was termed ubinu-
clein (ubiquitously expressed nuclear protein), and the
corresponding human gene was termed UBN1. A most in-
teresting morphological observation in keratinocyte cul-
tures was that transfection with the full-length ubinuclein
construct (Ubi-F) was associated with migration and
spreading of the cells in vitro. The spread-out, flattened
cells showed ubinuclein staining, in addition to nucleus,
also in the cytoplasm. Eventually, these cells appeared to
disintegrate and shed off from the top layer of the cultured
cells. These observations, which were only noted with the
full-length construct, but not with shortened constructs
(Ubi-N and Ubi-Z), suggest a selective and specific biolog-
ical role for ubinuclein in the differentiation of epidermal
keratinocytes.
Ubinuclein Is Ubiquitously Expressed in
Various Tissues
Ubinuclein is actively transcribed in essentially all tissues
and cells, a notion supported by abundance of cDNA
clones in the EST database. The high degree of homology
between EST sequences representing different species and
especially including the sequences within the 39-UTR, sug-
gests potential importance for this novel transcript and the
corresponding protein. The usage of two alternative pro-
moters, characterized from the genomic DNA sequence
and detected within the mRNA population through RT-
PCR analysis, suggests the possibility for tissue-specific and
constitutive or inducible expression of the transcripts.
Ubinuclein Shares Structural Features with
Nuclear Proteins
The isolation of a cDNA clone encoding a partial ubinu-
Figure 10. Ubinuclein inter-
acts with the basic domain of
transcription factors. A, The
Ubi-Z/ZAP5–GST fusion
protein pull-down assay was
performed with the in vitro-
translated EB1, ZJ (the basic
domain of EB1 replaced with
the basic domain of c-Jun),
and C/EBP. B, The EMSA
assay showed that in vitro-
translated ubinuclein (Ubi-
Z/ZAP5) binds to in vitro-
translated EB1 and EB1gcn4,
competing with their binding
to an oligonucleotide con-
taining the AP1 consensus
sequence.Aho et al. Ubinuclein, a Novel Nuclear Protein 1175
clein polypeptide through binding to an upstream element,
NRE1, in the LTR of the HIV1 promoter, and through the
interaction with an EBV transcription factor, EB1, sug-
gested the presence of functional binding domains within
the central region of ubinuclein. The detailed analysis
of full-length sequence revealed that ubinuclein indeed
shares features with nuclear proteins.
Nucleolin is an acidic protein with specific domains that
allow its binding with RNA, DNA, and proteins (see refer-
ences in Ginisty et al., 1999). Although ubinuclein is an
unusually basic protein, the presence of highly acidic re-
gions separated from each other by basic sequences at the
NH2-terminal region makes it structurally related to nucle-
olin. The alternating acidic and basic domains potentially
form loops that facilitate binding to both DNA and other
proteins. The difference between the predicted and the ap-
parent (SDS-PAGE–derived) molecular mass of nucleolin
has been attributed to a high content of negatively charged
amino acids. Also, the calculated molecular mass for ubi-
nuclein, 121,529 D, is lower than 150 kD, derived from
SDS-PAGE. The discrepancy between the predicted and
observed molecular mass may also be due to posttransla-
tional modifications, especially to the numerous potential
phosphorylation sites.
The NH2-terminal domain of ubinuclein showed se-
quence homology with the Drosophila yemanuclein-a
both on DNA and amino acid levels. In fact, the majority
of the ubinuclein 59-end EST clones had been identified
as similar to the Drosophila yemanuclein-a (GenBank/
EMBL/DDBJ P25992). Comparison of the human ubinu-
clein and Drosophila yemanuclein-a amino acid sequences
revealed within the 247 NH2-terminal amino acid residues
32.4% identity and 46.6% similarity. Another region of
ubinuclein, amino acids 351–624, revealed 22.6% identity
and 44.9% similarity to yemanuclein-a. It was reported re-
cently that the 59-coding sequence, but not the 59- or 39-
UTR, is necessary for the early accumulation of yema-
nuclein-a mRNA in the oocyte and for its localization
pattern during oogenesis (Capri et al., 1997). The first 500
bp of the ubinuclein open reading frame showed 52.6%
identity with the corresponding region of yemanuclein-a
cDNA. The function of this region of ubinuclein transcript
remains to be studied. The Drosophila yemanuclein-a is a
basic, serine-rich nuclear protein, which was originally iso-
lated through search for differentially expressed maternal
genes in Drosophila (Aït-Ahmed et al., 1987). The yema-
nuclein-a transcript is specifically expressed in the female
germ cells at early oogenic stages and displays a graded
distribution along the antero–posterior axis of the oocyte,
thus potentially playing a role in egg organization (Aït-
Ahmed et al., 1992). However, in contrast to the yemanu-
clein-a transcript, the ubinuclein transcript was detected in
essentially all adult and fetal tissues.
Functional analysis by cell transfections showed that the
NH2 terminus of 346 amino acids, which includes the ma-
jority of the putative nuclear localization signals, is suffi-
cient for the exclusive nuclear localization of ubinuclein in
keratinocytes. However, the NH2-terminally deleted Ubi-
Z/ZAP5, which also contains several putative nuclear lo-
calization signals, was found both in the cytoplasm and in
the nucleus of the keratinocytes.
Within the COOH-terminal domain of ubinuclein, a re-
gion rich in hydroxy amino acid residues, notably serines,
was detected. This type of sequence domain is characteris-
tic for nuclear proteins. For example, another speckled-
type nuclear protein, also known as pinin, belongs to the
class of proteins termed domain rich in serines (DRS) pro-
teins (Brandner et al., 1998).
Viral versus Cellular Transcription Factors
The EBV EB1 protein is a transcription factor belonging
to the bZIP family of nuclear proteins, which serve as
components for dimeric transcription factors collectively
called AP1 (Speck et al., 1997). Our results showed that in
vitro-translated ubinuclein (Ubi-Z/ZAP5) prevented EB1
from binding to DNA. The dimerization of EB1, either
through the authentic dimerization domain or through the
GCN4 dimerization domain, is a prerequisite for binding.
Specific amino acid residues in the EB1 dimerization do-
main are not essential for the in vitro interaction between
ubinuclein and EB1. Rather, it seems that a specific con-
formation of the basic domain imposed by the dimeriza-
tion event is the prerequisite for binding. Recently, a
nuclear chaperone regulating the dimerization of bZIP
proteins has been characterized (Virbasius et al., 1999).
Also, a possible function for ubinuclein in vivo might be
that it acts as a chaperone for bZIP factors, in which case
ubinuclein mediates impairment of EB1 and EB1gcn4 bind-
ing to DNA. It has been shown that phosphorylation of a
serine residue at position 186 in the basic domain of EB1
by protein kinase C, although it impairs EB1 binding to
DNA in vitro, increases EB1-mediated activation of tran-
scription (Baumann et al., 1998). Other cellular bZIP pro-
teins are also regulated by phosphorylation/dephosphory-
lation at or near the basic domain (see references in Karin,
1994; Su and Karin, 1996). Whether ubinuclein is an active
coregulator in these processes remains to be evaluated.
The immediate early transcription factor EB1 is respon-
sible for the initiation of the lytic cycle of EBV in human
epithelial keratinocytes. Overexpression of the EB1 in pri-
mary keratinocytes in culture seemed to downregulate the
level of the endogenous ubinuclein. The consequence of
the overexpression of ubinuclein, after the initial nuclear
and nucleolar localization, was seen as the cytoplasmic dis-
tribution of the protein, followed by spreading and shed-
ding of the transfected cells, which resembled the prema-
ture terminal differentiation event. The overexpression of
transfected ubinuclein in the same cell with EB1 resulted
in the cytoplasmic distribution of EB1 as well. These re-
sults suggest that ubinuclein and EB1 are able to interact
in vivo, which was detected as colocalization, and is re-
sponsible for redistribution of otherwise exclusively nu-
clear EB1 protein. Cellular concentration, as well as distri-
bution, of EB1 and ubinuclein proteins may be important
factors in the reactivation of the productive cycle in la-
tently infected epithelial cells.
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